Contraceptive Market, By Type, By Route of Administration, By Age Group, By Distribution Channel, By Geography
상품코드:1707287
리서치사:Coherent Market Insights
발행일:2025년 03월
페이지 정보:영문
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 피임약 시장은 2025년에 197억 9,000만 달러에 달하고, 2032년에는 471억 4,000만 달러에 이를 것으로 예측되며, 2025년부터 2032년까지의 연평균 성장률(CAGR)은 13.2%를 나타낼 전망입니다.
보고 범위
보고서 세부정보
기준 연도
2024년
시장 규모(2025년)
197억 9,000만 달러
실적 데이터
2020-2024년
예측 기간
2025-2032년
예측 기간 : 2025-2032년 CAGR :
13.20%
가치 예측(2032년)
471억 4,000만 달러
그림. 피임약 시장 점유율(%), 지역별(2025년)
세계의 피임약 시장은 지난 수십 년에 걸쳐 꾸준한 성장을 이루고 있습니다. 피임약은 일반적으로 여성 호르몬인 에스트로겐과 프로게스테론의 합성판을 포함하고 있습니다. 배란을 억제하고 자궁 경관 점액과 자궁 내막을 변화 가족계획에 대한 사고방식의 변화, 예정외의 임신에 대한 우려가 높아지고, 성건강에 대한 의식이 높아지고, 피임옵션에 관한 규제규범의 엄격화 등이 피임약 수요를 세계적으로 밀어 올리고 있습니다.
시장 역학 :
여성의 인식률이 높아지고 임파워먼트가 피임약 시장을 전진시키는 주요 요인입니다. 급속한 도시화, 라이프 스타일의 변화, 현대적인 건강 관리에 대한 쉬운 접근은 경구 피임약을 선택하는 여성을 늘리고 있습니다. 메트 메디컬 니즈를 해결하기 위한 기술 혁신과 마찬가지로, 효과성이 향상되고 부작용이 적은 신제품의 출현은 시장 기업에게 유리한 성장 기회를 만들어 냈습니다. 피임기구의 존재, 혈전, 우울증, 체중 변화 등 호르몬제에 따른 부작용이 시장 성장의 방해가 되고 있습니다. 또한, 일부 지역에서는 사회적 낙인이나 종교적 사양이 피임약 수요를 계속 억제하고 있습니다.
본 조사의 주요 특징
본 보고서에서는 세계의 피임약 시장을 상세하게 분석하여 2024년을 기준 연도로 한 예측기간(2025-2032년) 시장 규모 및 복합연간 성장률(CAGR)을 제공합니다.
또, 다양한 부문에 걸친 잠재적인 수익 성장 기회를 밝혀, 이 시장의 매력적인 투자 제안 매트릭스에 대해서 해설했습니다.
또, 시장 성장 촉진요인, 성장 억제요인, 기회, 신제품의 출시나 승인, 시장 동향, 지역별 전망, 주요 시장 기업이 채용하는 경쟁 전략 등에 관한 중요한 인사이트도 제공합니다.
기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략 등의 파라미터에 근거해, 세계의 피임약 시장 주요 기업 프로파일을 제공합니다.
이 보고서의 인사이트는 마케팅 담당자와 기업 경영진이 향후 제품 출시, 유형 업그레이드, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 할 수 있게 합니다.
세계의 피임약 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통 업체, 신규 참가자, 재무 분석가 등이 업계의 다양한 이해 관계자에 대응하고 있습니다.
세계의 피임약 시장을 분석할 때 사용되는 다양한 전략 매트릭스를 통해 이해관계자는 의사결정이 용이해집니다.
제1장 조사의 목적과 전제조건
조사 목적
전제조건
약어
제2장 시장 전망
보고서 설명
시장 정의와 범위
주요 요약
일관된 기회 맵(COM)
제3장 시장 역학, 규제, 동향 분석
시장 역학
성장 촉진요인
피임약의 인기 증가
가족계획과 피임에 대한 접근을 촉진하기 위한 정부의 이니셔티브 확대
성장 억제요인
정제에 수반하는 부작용
혈전이나 심혈관 질환의 위험
기회
신흥 국가 수요 증가
피임약을 선택하는 여성 인구 증가
주요 하이라이트
최근 동향
PEST 분석
PORTER 분석
최근 제품 승인/발매
합병, 인수 및 제휴
제4장 세계의 피임약 시장 - 코로나바이러스(COVID-19) 팬데믹의 영향
COVID-19 역학
공급측과 수요측의 분석
경제에 미치는 영향
제5장 세계의 피임약 시장, 유형별(2020-2032년)
복합 피임약
단상 알약
다상 알약
연장주기 알약
호르몬 피임약
프로게스틴 전용 알약
응급피임약
레보놀 게스트렐 기반
우리프리스탈 아세테이트베이스
제6장 세계의 피임약 시장, 투여 경로별(2020-2032년)
경구
주사제
자궁 내
질
기타(패치 등)
제7장 세계의 피임약 시장, 연령층별(2020-2032년)
청소년
성인
제8장 세계의 피임약 시장, 유통 채널별(2020-2032년)
온라인 약국
병원 약국
소매 약국
제9장 세계의 피임약 시장, 지역별(2020-2032년)
북미
유럽
아시아태평양
라틴아메리카
중동
아프리카
제10장 경쟁 구도
기업 프로파일
Bayer AG
Pfizer Inc.
Teva Pharmaceutical Industries
Merck &Co.
Janssen Pharmaceutical Companies
Allergan
Piramal Enterprises
Glenmark Pharmaceuticals
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Mithra Pharmaceuticals
Gedeon Richter
HLL Lifecare
Cadila Healthcare
Organon
Other Prominent Players
제11장 섹션
참고문헌
조사 방법
출판사에 대해
KTH
영문 목차
영문목차
Global Contraceptives Market is estimated to be valued at USD 19.79 Bn in 2025 and is expected to reach USD 47.14 Bn by 2032, growing at a compound annual growth rate (CAGR) of 13.2% from 2025 to 2032.
Report Coverage
Report Details
Base Year:
2024
Market Size in 2025:
USD 19.79 Bn
Historical Data for:
2020 To 2024
Forecast Period:
2025 To 2032
Forecast Period 2025 to 2032 CAGR:
13.20%
2032 Value Projection:
USD 47.14 Bn
Figure. Contraceptives Market Share (%), By Region 2025
Global contraceptive pill market has been witnessing steady growth over the past few decades. Contraceptive pills, commonly known as birth control pills, contain synthetic versions of the female sex hormones - estrogen and progesterone. They are taken orally to prevent pregnancy by inhibiting ovulation and altering cervical mucus and the lining of the uterus. Changing attitudes towards family planning, rising concern about unplanned pregnancies, growing sexual health awareness, and stricter regulatory norms regarding contraceptive options have boosted the demand for contraceptive pills globally. Moreover, increasing women workforce participation and delayed pregnancies have further augmented the acceptance of oral contraceptive drugs.
Market Dynamics:
Rising female literacy and empowerment are the primary drivers propelling the contraceptive pill market forward. Growing awareness about women's reproductive health and rights has led to a widespread acceptance of contraceptives to delay or plan pregnancies. Rapid urbanization, changing lifestyles, and easier access to modern healthcare are encouraging more women to opt for oral contraceptives. At the same time, the emergence of new products with improved efficacy and fewer side effects as well as innovations to address unmet medical needs in contraception are creating lucrative growth opportunities for market players. However, the presence of alternative family planning methods and contraceptive devices along with some side effects that are associated with hormonal pills such as blood clots, depression, and weight changes are hindering the market growth. Moreover, social stigma and religious reservations in some regions continue to restrain the demand for contraceptive pills.
Key Features of the Study:
This report provides an in-depth analysis of the global contraceptive market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key market players
It profiles key players in the global contraceptive market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Bayer AG, Pfizer Inc., Teva Pharmaceutical Industries, Merck & Co., Janssen Pharmaceutical Companies, Allergan, Piramal Enterprises, Glenmark Pharmaceuticals, Lupin Pharmaceuticals, Mylan Pharmaceuticals, Mithra Pharmaceuticals, Gedeon Richter, HLL Lifecare, Cadila Healthcare, Organon and Other Prominent Players
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global contraceptive market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global contraceptive market
Detailed Segmentation:
Global Contraceptive Market, By Type
Combination Contraceptives
Monophasic pills
Multiphasic pills
Extended-cycle pills
Hormonal Contraceptives
Progestin-Only Pills
Emergency Contraceptives
Levonorgestrel-based
Ulipristal acetate-based
Global Contraceptive Market, By Route of Administration
Oral
Injectable
Intrauterine
Vaginal
Others (Patches, etc.)
Global Contraceptive Market, By Age Group
Adolescents
Adults
Global Contraceptive Market, By Distribution Channel
Online Pharmacies
Hospital Pharmacies
Retail Pharmacies
Global Contraceptive Market, By Region
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Company Profiles
Bayer AG
Pfizer Inc.
Teva Pharmaceutical Industries
Merck & Co.
Janssen Pharmaceutical Companies
Allergan
Piramal Enterprises
Glenmark Pharmaceuticals
Lupin Pharmaceuticals
Mylan Pharmaceuticals
Mithra Pharmaceuticals
Gedeon Richter
HLL Lifecare
Cadila Healthcare
Organon
Other Prominent Players
Table of Contents
1. Research Objectives and Assumptions
Research Objectives
Assumptions
Abbreviations
2. Market Purview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Type
Market Snippet, By Route of Administration
Market Snippet, By Age Group
Market Snippet, By Distribution Channel
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers:
Increasing popularity of contraceptive drugs
Growing government initiatives for promoting access to family planning and contraceptives
Restraints
Side effects associated with pills
Risks of blood clots and cardiovascular diseases
Opportunities
Growing demand in developing countries
Growing female population opting for contraceptive drugs
Key Highlights
Recent Trends
PEST Analysis
PORTER's Analysis
Recent Product Approvals/Launches
Mergers, Acquisitions, and Collaborations
4. Global Contraceptive Market- Impact of Coronavirus (COVID-19) Pandemic
COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact
5. Global Contraceptive Market, By Type, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Combination Contraceptives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Monophasic pills
Multiphasic pills
Extended-cycle pills
Hormonal Contraceptives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Progestin-Only Pills
Emergency Contraceptives
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Levonorgestrel-based
Ulipristal acetate-based
6. Global Contraceptive Market, By Route of Administration, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Injectable
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Intrauterine
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Vaginal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Others (Patches, etc.)
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
7. Global Contraceptive Market, By Age Group, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Adolescents
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Adults
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
8. Global Contraceptive Market, By Distribution Channel, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, 2025 and 2032 (%)
Y-o-Y Growth Analysis, 2021 - 2032
Segment Trends
Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Bn)
9. Global Contraceptive Market, By Region, 2020-2032, (US$ Bn)
Introduction
Market Share Analysis, By Region, 2025 and 2032 (%)
Y-o-Y Growth Analysis, For Region, 2021 - 2032
Country Trends
North America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
U.S.
Canada
Europe
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
Asia Pacific
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Latin America
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
Brazil
Argentina
Mexico
Rest of Latin America
Middle East
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032, (US$ Bn)
GCC Countries
Israel
Rest of Middle East
Africa
Introduction
Market Size and Forecast, and Y-o-Y Growth, By Type, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020-2032, (US$ Bn)
Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032, (US$ Bn)
